BABA
Alibaba Group Holding Limited
BABA's outlook is improving, though it still trails on the overall score.
HEPS
D-Market Elektronik Hizmetler ve Ticaret A.S.
HEPS has the edge over BABA overall, supported by stronger fundamentals.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
HEPS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Strong |
HEPS's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
HEPS PE Valuation
HEPS has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
HEPS Forward outlook
There aren't enough analyst estimates for HEPS to show an outlook.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over HEPS on earnings quality, reporting a profit while its opponent remains loss making.
HEPS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.44 | -$0.31 |
| Q1 2026 | -$0.39 | -$0.28 |
| Q4 2025 | -$0.35 | -$0.26 |
| Q3 2025 | -$0.19 | -$0.10 |
| Q2 2025 | -$0.13 | -$0.05 |
| Q1 2025 | -$0.11 | -$0.10 |
| Q4 2024 | -$0.09 | -$0.06 |
| Q3 2024 | -$0.09 | -$0.08 |
HEPS lost $0.44 per share over the past year, and its loss has widened in each of the last six quarters.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over HEPS on profitability, with a higher operating margin.
HEPS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $453.9M | +36% |
| Q1 2026 | $460.4M | +61% |
| Q4 2025 | $603.7M | +48% |
| Q3 2025 | $396.4M | +63% |
| Q2 2025 | $333.2M | +23% |
| Q1 2025 | $286.3M | -7.9% |
| Q4 2024 | $406.7M | +46% |
| Q3 2024 | $243.6M | +1.7% |
HEPS's revenue has grown year over year for five quarters in a row: $454M last quarter, up 36% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.9% | -3.1 points |
| Q1 2026 | -1.9% | +1.9 points |
| Q4 2025 | 0.9% | +0.3 points |
| Q3 2025 | -3% | -3.2 points |
| Q2 2025 | 0.2% | +0.5 points |
| Q1 2025 | -3.8% | -2.9 points |
| Q4 2024 | 0.7% | +2.6 points |
| Q3 2024 | 0.3% | +2.3 points |
HEPS's operating margin was −2.9% last quarter, down 3.1 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
HEPS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $29.3M | -56% |
| Q1 2026 | -$61.5M | -$60.6M |
| Q4 2025 | $14.9M | +$15.4M |
| Q3 2025 | $438.9K | +30% |
| Q2 2025 | $66.5M | +$67.4M |
| Q1 2025 | -$928.4K | -510% |
| Q4 2024 | -$582.5K | -133% |
| Q3 2024 | $337.1K | -66% |
HEPS has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over HEPS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
HEPS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +3.1M shares |
| 1 year | +15% | +47.7M shares |
| 3 years | +14% | +44.2M shares |
| 5 years | +14% | +44.5M shares |
| Available history | +14% | +44.5M shares |
HEPS has 371M diluted shares, up 15% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
HEPS hasn't bought back shares in the past year.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
HEPS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -2.3x | Net Cash |
| Q1 2026 | -2.8x | Net Cash |
| Q4 2025 | -6.3x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
| Q3 2024 | -0.4x | Net Cash |
HEPS has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
HEPS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.7 | Neutral |
| Stochastic | 60.1 | Neutral |
HEPS's weekly RSI is 50 (neutral) and its Stochastic is 60 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
HEPS PE vs Consumer Cyclical Sector
| Metric | HEPS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
HEPS has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
HEPS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.68 | 1.1% above |
| 20 week MA | $2.73 | 0.7% below |
| 50 week MA | $2.73 | 0.7% below |
| 100 week MA | $2.79 | 2.9% below |
| 200 week MA | $2.28 | 19% above |
HEPS has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
HEPS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $14.1 | $2.05 | -85% |
| 2022 | $2.05 | $0.69 | -66% |
| 2023 | $0.69 | $1.80 | +161% |
| 2024 | $1.80 | $3.26 | +81% |
| 2025 | $3.26 | $2.52 | -23% |
| 2026 YTD | $2.52 | $2.71 | +7.5% |
HEPS has the edge over BABA on returns for 2026, with the stronger performance.